With MOLDERM^® GLOW+, unlike other HA-based products, we can give the fibroblast access to the really large HA molecules that were naturally present in our skin when we were younger. Due to their size, it takes longer to break them down with enzymes. Therefore, these large molecules in the “ultra-high molecular weight” spectrum stay longer on the receptor (CD44) to stimulate maximum production of proteins such as collagen and elastin.

As we age, the body’s production of hyaluronic acid decreases and the very largest chains become increasingly rare. With the MOLDERM^® GLOW+ molecular spectrum, the fibroblast can again produce collagen and elastin as it once did.

Now, as a practitioner, you no longer need to inject foreign material, create unnecessary trauma or inflammatory processes in your patient.

MOLDERM^® GLOW+ is a completely new formula of non-crosslinked hyaluronic acid in the spectrum - low, high and ultra-high molecular weight. It is designed for a more long-term, intensive and profound effect of biostimulation.

Our patented Fine-Tuning Technology™ allows us to focus on the molecular sizes that, via receptors, best stimulate the cells that are directly linked to the production of the human’s different types of collagen and elastin as well as various proteoglycans.

Overall, this means a significant reduction in the human skin aging process.

Obtained by biofermentation.

One syringe of MOLDERM^® GLOW+ is the last treatment in a Molderm^® regimen that also includes two syringes of MOLDERM^® GLOW.

One syringe of MOLDERM^® GLOW+ contains 2 ml, with 40 mg of hyaluronic acid.

Clinical resources for the GLOW and GLOW+ treatment sequence.